Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
Human Gene Therapy|November 17, 2006
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligandCarmelo Carlo-Stella, Cristiana Lavazza, Massimo Di Nicola, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantationLiliana Devizzi, Anna Guidetti, Corrado Tarella, et al.Experimental Hematology|April 23, 2004
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormoneCarmelo Carlo-Stella, Massimo Di Nicola, Raffaella Milani, et al.Cancer Research|October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic deathRoberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.Blood|January 17, 2004
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizersCarmelo Carlo-Stella, Massimo Di Nicola, Raffaella Milani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsPaolo Corradini, Anna Dodero, Francesco Zallio, et al.Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.Experimental Hematology|May 27, 2006
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID miceCarmelo Carlo-Stella, Anna Guidetti, Massimo Di Nicola, et al.American Journal of Clinical Oncology|August 5, 2014
Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell TumorsDaniele Raggi, Patrizia Giannatempo, Rosalba Miceli, et al.Stem Cells (Dayton, Ohio)|September 30, 2006
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primatesCarmelo Carlo-Stella, Massimo Di Nicola, Paolo Longoni, et al.Pageof 8